| Téléchargement | - Voir la version finale : Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives (PDF, 211 Kio)
|
|---|
| Auteur | Rechercher : Schoenhofen, Ian1; Rechercher : Whitfield, Dennis M.1 |
|---|
| Affiliation | - Conseil national de recherches du Canada. Institut des sciences biologiques du CNRC
|
|---|
| Format | Texte, Allocution |
|---|
| Conférence | The Crossroad for Biotransfer 2010, May 18, 2010, Boston, Massachusetts, United States |
|---|
| Description physique | 1 p. |
|---|
| Résumé | There is clearly an unmet need for anti-influenza drugs that are more effective than those currently available, and ideally that are effective against various strains of influenza and that are not prone to the development of resistance. The unique features of the NRC-IBS technology, with its anticipated efficacy against numerous strains, possibly including avian flu, will enable it to compete effectively against such products. We also note that the market is quite large, and is likely to continue to grow over the coming years. The technology may also result in the development of agents against other viral infections, and against bacterial infections. |
|---|
| Date de publication | 2010-05-01 |
|---|
| Maison d’édition | National Research Council of Canada |
|---|
| Dans | |
|---|
| Langue | anglais |
|---|
| Publications évaluées par des pairs | Oui |
|---|
| Numéro NPARC | 17442572 |
|---|
| Exporter la notice | Exporter en format RIS |
|---|
| Signaler une correction | Signaler une correction (s'ouvre dans un nouvel onglet) |
|---|
| Identificateur de l’enregistrement | 0c36bca9-da1a-48cd-9eff-b526aceb2556 |
|---|
| Enregistrement créé | 2011-04-08 |
|---|
| Enregistrement modifié | 2022-07-12 |
|---|
